Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology
Group Leader

Kevin Wang

Northwell Health
Fellow

Hematology oncology fellow with interests in general hematology oncology. Passionate about education and research.

 

Group Co-Leader

Nagashree Seetharamu

Northwell Health/Hofstra
MD/Associate Professor

I am the director of thoracic and head and neck medical oncology at Northwell Health. I am a clinical researcher and serve as a principal investigator on a multitude of clinical trials. I am an educator and enjoy working with fellows, residents and students. My specific areas of interest are prevention, early detection and cancer biomarkers.